Inventor
ONIONS STUART THOMAS
GB61 patents
⚠️ This page may combine multiple inventors who share the name “ONIONS STUART THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RESPIVERT LTD
22 patentsUS9108950B2Aug 18, 2015
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors
RESPIVERT LTD38 citations96
US9624196B2Apr 18, 2017
Inhibitor of p38 MAP kinase
RESPIVERT LTD15 citations92
US9475796B2Oct 25, 2016
1-pyrazolyl-3-((4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors
RESPIVERT LTD12 citations92
US9447076B2Sep 20, 2016
Inhibitor of p38 map kinase
RESPIVERT LTD16 citations92
US8975285B2Mar 10, 2015
P38 MAP kinase inhibitors
RESPIVERT LTD26 citations92
US9249125B2Feb 2, 2016
Pyrazole derivatives as p38 MAP inhibitors
RESPIVERT LTD30 citations91
US9724347B2Aug 8, 2017
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors
RESPIVERT LTD5 citations84
US10266519B2Apr 23, 2019
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors
RESPIVERT LTD6 citations82
US9850231B2Dec 26, 2017
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors
RESPIVERT LTD5 citations82
US9701670B2Jul 11, 2017
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD10 citations80
US10238658B2Mar 26, 2019
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors
RESPIVERT LTD3 citations73
US9993478B2Jun 12, 2018
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors
RESPIVERT LTD2 citations73
US10294216B2May 21, 2019
Pyrazolyl ureas as kinase inhibitors
RESPIVERT LTD1 citations72
US10738032B2Aug 11, 2020
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-i-yl) ureas as P38 mapkinase inhibitors
RESPIVERT LTD3 citations71
US9227977B2Jan 5, 2016
Phosphoinositide 3-kinase inhibitors
RESPIVERT LTD4 citations71
US11634406B2Apr 25, 2023
Inhibitor of p38 MAP kinase
RESPIVERT LTD0 citations62
US11142515B2Oct 12, 2021
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD0 citations61
US10358445B2Jul 23, 2019
Respiratory formulations and compounds for use therein
RESPIVERT LTD1 citations61
US9884845B2Feb 6, 2018
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD1 citations61
US10813932B2Oct 27, 2020
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors
RESPIVERT LTD0 citations52
US10815217B2Oct 27, 2020
Inhibitor of p38 MAP kinase
RESPIVERT LTD0 citations51
US10045980B2Aug 14, 2018
Inhibitor of p38 map kinase
RESPIVERT LTD0 citations51
PULMOCIDE LTD
9 patentsUS10106531B2Oct 23, 2018
Compound useful to treat mycoses
PULMOCIDE LTD10 citations92
US11661415B2May 30, 2023
Process for preparing a compound useful to treat mycoses
PULMOCIDE LTD2 citations84
US10858345B2Dec 8, 2020
Process for preparing a compound useful to treat mycoses
PULMOCIDE LTD3 citations84
US10662179B2May 26, 2020
Process for preparing a compound useful to treat mycoses
PULMOCIDE LTD3 citations84
US10450304B2Oct 22, 2019
Compound useful to treat mycoses
PULMOCIDE LTD4 citations84
US10344022B2Jul 9, 2019
Compound useful to treat mycoses
PULMOCIDE LTD7 citations84
US10035810B2Jul 31, 2018
5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative
PULMOCIDE LTD2 citations72
US10189863B2Jan 29, 2019
5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives
PULMOCIDE LTD3 citations71
US12269814B2Apr 8, 2025
Process for preparing a compound useful to treat mycoses
PULMOCIDE LTD0 citations62
ITO KAZUHIRO
5 patentsUS8618140B2Dec 31, 2013
P38 MAP kinase inhibitors
ITO KAZUHIRO41 citations97
US8299073B2Oct 30, 2012
P38 MAP kinase inhibitors
ITO KAZUHIRO50 citations97
US8299074B2Oct 30, 2012
P38 MAP kinase inhibitors
ITO KAZUHIRO48 citations97
US8293748B2Oct 23, 2012
p38 MAP kinase inhibitors
ITO KAZUHIRO47 citations97
US8293771B2Oct 23, 2012
p38 MAP kinase inhibitors
ITO KAZUHIRO49 citations97
OTSUKA PHARMA CO LTD
3 patentsUS10457669B2Oct 29, 2019
Benzolactam compounds as protein kinase inhibitors
OTSUKA PHARMA CO LTD5 citations82
US11001575B1May 11, 2021
Benzolactam compounds as protein kinase inhibitors
OTSUKA PHARMA CO LTD4 citations71
US11939321B2Mar 26, 2024
Benzolactam compounds as protein kinase inhibitors
OTSUKA PHARMA CO LTD0 citations61
HUNT SIMON FRASER
2 patentsKING-UNDERWOOD JOHN
2 patentsCELLCENTRIC LTD
2 patentsMURRAY PETER JOHN
1 patentMOFFAT DAVID FESTUS CHARLES
1 patentCHROMA THERAPEUTICS LTD
1 patentMOFFAT DAVID CHARLES FESTUS
1 patentBERGENBIO ASA
1 patentShowing the top 50 of 61 patents by PatentIndex Score.